Rock Point Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-2,026
Closed -$211K 78
2017
Q4
$211K Hold
2,026
0.1% 66
2017
Q3
$295K Hold
2,026
0.14% 56
2017
Q2
$263K Hold
2,026
0.12% 64
2017
Q1
$252K Hold
2,026
0.13% 62
2016
Q4
$235K Sell
2,026
-9
-0.4% -$1K 0.12% 70
2016
Q3
$213K Hold
2,035
0.11% 71
2016
Q2
$201K Buy
+2,035
New +$210K 0.11% 72
2016
Q1
Sell
-1,845
Closed -$221K 84
2015
Q4
$221K Sell
1,845
-45
-2% -$5.21K 0.12% 68
2015
Q3
$204K Hold
1,890
0.11% 72
2015
Q2
$219K Sell
1,890
-100
-5% -$11.4K 0.11% 73
2015
Q1
$229K Sell
1,990
-28
-1% -$3.35K 0.11% 69
2014
Q4
$226K Buy
+2,018
New +$213K 0.1% 69

Other funds holding CELG

Rock Point Advisors's CELG Position: Q1 2018 in Review

Rock Point Advisors sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 2,026 shares — an estimated $211K sold.

Rock Point Advisors first reported a position in CELG in Q4 2014 and held it in 12 quarters. The position peaked at $295K in Q3 2017. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

  • Rock Point Advisors reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
  • Rock Point Advisors sold 2,026 Celgene Corp shares in Q1 2018, an estimated $211K.
  • Rock Point Advisors first reported a position in Celgene Corp in Q4 2014 and held it in 12 quarters.
  • Rock Point Advisors's Celgene Corp position peaked at $295K in Q3 2017.
  • 1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Rock Point Advisors's 13F filing for Q1 2018, filed 11 May 2018.